Liver Biopsy Market size was valued at USD 5505.71 million in 2023, and is estimate to reach USD 9249.79 million by 2031, with growing CAGR of 6.7% over the forecast period 2024-2031.
It has been seemed as the market for liver biopsies has grown and developed significantly in recent years. This expansion can be linked to a number of variables, such as the rising incidence of liver illnesses globally, improvements in biopsy methods, and the rising demand for precise diagnostic procedures. Liver conditions include hepatitis, NAFLD, and liver cancer have grown to be serious global health issues. The demand for liver biopsies has increased as a result of the increasing prevalence of various diseases, as well as expanding awareness and early detection measures. Furthermore, a liver biopsy offers crucial information for a precise diagnosis and sensible therapy planning because liver illnesses frequently have modest symptoms.
The liver biopsy market has expanded as a result of technological development. The percutaneous technique used in conventional liver biopsy procedures required the use of a needle to be injected into the liver through the skin. Trans jugular and laparoscopic biopsies, however, have become more popular because to their reduced risk of complications and speedier recovery times. Additionally, the accuracy and safety of the process have been enhanced by the advent of imaging-guided liver biopsy techniques using magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. These imaging techniques support accurate needle placement, lowering the possibility of problems and providing higher-quality samples.
The market for non-invasive alternatives, like blood-based biomarker tests and imaging methods like elastography, is also advancing. These substitutes seek to deliver accurate diagnostic data without requiring a tissue sample. Despite their potential, liver biopsy is still the gold standard for conclusive staging and diagnosis of liver disorders. A thorough market segmentation study of the liver biopsy market based on variables such as Healthcare of Liver biopsy, Healthcare of Liver biopsy, End-User, technology, and geography are often included in the research. Understanding the many categories and their own markets, growth rates, and prospects is made easier by this segmentation.
The COVID-19 pandemic has had a major effect on a number of industries, notably the healthcare sector. The market for liver biopsies has also been impacted in a number of ways:
Procedures were postponed or scaled back as a result of the pandemic, including liver biopsies, which were one of the procedures that had to be delayed or reduced. The number of liver biopsy operations was reduced as hospitals and clinics concentrated their efforts on treating COVID-19 patients. The market for liver biopsies as a whole suffered from this decrease in operations.
Patients may not have visited medical facilities because they were afraid of getting sick from the illness. Even when liver biopsies were required for diagnosis, fewer people sought them out as a result of their anxiety and reluctance. The market demand for liver biopsy instruments and related items was impacted by the decrease in patient volumes.
Drivers
Growing Incidence of Liver disorders: The liver biopsy market is mostly driven by the growing prevalence of liver disorders such liver cirrhosis, hepatitis, and liver cancer. Accurate diagnosis and staging are required due to the increasing prevalence of these illnesses, which liver biopsies can offer. Technologies have enhanced the safety, accuracy, and patient experience of liver biopsies with the introduction of new biopsy methods, imaging technologies, and less invasive techniques. Because more people are using liver biopsy procedures as a result of these technical developments, the market is growing boosting market growth.
Restraints
The analysis of liver biopsy samples calls for knowledge and experience.
The process of a liver biopsy entails taking tissue samples, which for some individuals may be morally troubling.
The liver biopsy process is invasive and comes with a modest risk of consequences, such as bleeding and infection. The invasiveness and potential hazards of liver biopsy treatments may cause some patients and medical professionals to hesitate to choose them. Non-invasive alternatives are becoming more popular as they offer diagnostic data without requiring an intrusive treatment. Examples include imaging techniques (elastography) and blood-based biomarker assays. The expansion of the liver biopsy market is hampered by the availability of these substitutes.
Opportunities
Precision diagnosis and personalized medicine: By shedding light on the molecular and genetic aspects of liver disorders, liver biopsy plays a key part in personalized therapy. The market for liver biopsies has an opportunity to adapt to the changing demands of targeted medicines and precision diagnostics due to the increased emphasis on personalized medicine with their expanding healthcare systems and increased incidence of liver illnesses, emerging markets offer the liver biopsy market tremendous room for expansion. Market expansion in these areas is fueled by improved access to healthcare facilities, greater patient populations, and rising awareness.
Challenges
The development of the market for liver biopsy therapy faces a challenge from the accessibility and uptake of non-invasive diagnostic technologies.
For the operation to be safer and more comfortable for the patient, concerns about the invasiveness and potential hazards of liver biopsy must be addressed.
The cost of the process, the equipment, and the histological examination of the biopsy samples can all contribute to the expense of liver biopsy procedures. The cost element might be problematic, especially in healthcare settings with limited resources and for people without proper insurance.
Challenges with Regulation and Reimbursement: The acceptance and use of liver biopsy methods might be influenced by regulatory regulations and reimbursement guidelines. For market participants operating in several areas, ensuring compliance with regulatory criteria and obtaining favorable reimbursement can be difficult.
Healthcare Infrastructure Disruption: In areas where the conflict is being fought, healthcare infrastructure may be negatively impacted. Hospitals, clinics, and healthcare facilities might sustain damage or be completely destroyed, limiting availability to medical treatments like liver biopsy operations. Infrastructure problems can have a substantial impact on the accessibility and availability of healthcare services, thereby lowering the frequency of liver biopsy treatments.
Migration and Population Displacement: During armed conflicts, individuals frequently migrate away from afflicted areas in search of safety. Due to the potential for overpopulation, access to basic healthcare, particularly specialized treatments like liver biopsies, may be restricted in refugee camps or other temporary settlements. The increased demand on healthcare services in the host regions might put a strain on resources and affect the availability of elective surgery.
Impact of Ongoing Recession
Healthcare Spending Reduction: During a recession, people and healthcare systems frequently have financial difficulties. Spending on healthcare might decrease as a result, especially on elective operations like liver biopsies. Due to patient financial worries, non-essential medical operations may be postponed or skipped, which might reduce the frequency of liver biopsy procedures. The income and market expansion of the liver biopsy might be impacted by this decline in operation volumes.
Limited Access to Healthcare Services: Economic downturns can cause people to lose their jobs, have their insurance coverage cut, or incur higher out-of-pocket costs. Access to healthcare treatments, such as liver biopsy procedures, may be restricted as a result. Patients may have trouble paying for the surgery or encounter difficulties getting timely referrals or might encounter obstacles when trying to get appointments or referrals on schedule. The demand for liver biopsy operations can be directly impacted by reduced access to healthcare services, which can therefore change the market's dynamics.
Delayed Investments and Purchases: During a recession, healthcare institutions including hospitals, clinics, and nursing homes could encounter financial limitations that affect their investment and purchase decisions. As healthcare providers place a higher priority on necessary expenses, capital investments in new liver biopsy devices and equipment can be delayed or postponed. The growth and market size of manufacturers and providers of liver biopsy devices may be impacted by the decreased investments and postponed purchases.
By Procedure
Percutaneous Biopsy
Trans jugular Biopsy
Laparoscopic Biopsy
Robotic Biopsy
By End-User
Hospitals
Clinics and Ambulatory Surgical Centers
Research and Academic Institutes
By Application
Liver Cirrhosis
Hepatitis
Liver Cancer
Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
Other Liver Diseases
By Technology
Conventional Biopsy Needles:
Vacuum-Assisted Biopsy Systems
Image-Guided Biopsy
Other Emerging Technologies
.png)
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Due to the high frequency of liver illnesses and the developed healthcare system in North America, the region accounts for a sizeable portion of the global market for liver biopsies.
The existence of significant market participants, technical breakthroughs, and benevolent reimbursement policies all support market expansion. Additionally, non-invasive diagnostic options and minimally invasive liver biopsy methods are becoming more popular in the region.
The liver biopsy market is expanding significantly in the Asia Pacific area as a result of factors such a high patient population, rising healthcare costs, and growing public awareness of liver illnesses. The need for liver biopsy operations is rising as a result of rapid urbanisation, changing lifestyles, and the high prevalence of hepatitis B and C.An increase in liver disease rates in developing nations like China and India is opening up new business prospects.
The key players are Becton, Dickinson and Company (BD), Cook Medical, Medtronic placebos Scientific Corporation, Olympus Corporation, Veran Medical Technologies, Angiotech Pharmaceuticals, TSK Laboratory, Cardinal Health, SOMATEX Medical Technologies, Argon Medical Devices, Med axiom Corporation, Merit Medical Systems, Path Group & Other Players.
| Report Attributes | Details |
| Market Size in 2023 | US$ 5505.71 Mn |
| Market Size by 2031 | US$ 9249.79 Mn |
| CAGR | CAGR of 6.7% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Procedure (Percutaneous Biopsy, Trans jugular Biopsy, Laparoscopic Biopsy, Robotic Biopsy) • By End User (Hospitals, Clinics and Ambulatory surgical centers) • By Application (Liver cirrhosis, Hepatitis, Liver cancer, Nonalcoholic fatty liver disease) • By technology (Conventional Biopsy Needles, Vacuum assisted Biopsy, image Guided biopsy, other emerging technology) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Becton, Dickinson and Company (BD), Cook Medical, Medtronic placebos Scientific Corporation, Olympus Corporation, Veran Medical Technologies, Angiotech Pharmaceuticals, TSK Laboratory,Cardinal Health,SOMATEX Medical Technologies,Argon Medical Devices, Med axiom Corporation, Merit Medical Systems, Path Group. |
| Key Drivers |
|
| Market Opportunities |
|
Liver Biopsy Market size was valued at USD 5160 million in 2022, and is estimate to reach USD 8539 million by 2030.
The CAGR growth rate of liver biopsy market is approx. CAGR of 6.5% over the forecast period 2023-2030.
The major key players, Becton, Dickinson and Company (BD), Cook Medical, Medtronic placebos Scientific Corporation, Olympus Corporation, Veran Medical Technologies, Aggrotech Pharmaceuticals, TSK Laboratory, Cardinal Health, SOMATEX Medical Technologies, Argon Medical Devices, Med axiom Corporation, Merit Medical Systems, Path Group, Others.
North America is dominating the market and will continue to dominate the market during the forecasted period
Global Healthcare of Liver biopsy Market is divided into four segments.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of the Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global Healthcare of Liver biopsy Market Segmentation, By Procedure
8.1 Percutaneous Biopsy
8.2 Trans jugular
8.3 Laparoscopic Biopsy
8.4 Robotic Biopsy
9. Global Healthcare of Liver biopsy Market Segmentation, By End-User
9.1 Hospitals
9.2 Clinics and Ambulatory Surgical Centers
9.3 Research and Academic Institution
10. Global Healthcare of Liver biopsy Market Segmentation, By End-User
10.1 liver cirrhosis
10.2 Hepatitis
10.3 liver cancer
10.4 Non-alcoholic fatty liver diseases
11.Global Healthcare of Liver biopsy Market Segmentation, By technology
11.1 Conventional Biopsy Needles
11.2 Vaccum Assisted Biopsy
11.3 Image Cruided biopsy
11.4 Other emerging technology
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Global Healthcare of Liver biopsy Market by country
12.2.2 North America Global Healthcare of Liver biopsy Market by Procedure Type
12.2.3 North America Global Healthcare of Liver biopsy Market by End-User
12.2.4 North America Global Healthcare of Liver biopsy Market by Application
12.2.5 North America Global Healthcare of Liver biopsy Market by Technology
12.2.6 USA
12.2.6.1 USA Global Healthcare of Liver biopsy Market by Procedure Type
12.2.6.2 USA Global Healthcare of Liver biopsy Market by End-User
12.2.6.3 USA Global Healthcare of Liver biopsy Market by Application
12.2.6.4 USA Global Healthcare of Liver biopsy Market by Technology
12.2.7 Canada
12.2.7.1 Canada Global Healthcare of Liver biopsy Market by Procedure Type
12.2.7.2 Canada Global Healthcare of Liver biopsy Market by End-User
12.2.7.3 Canada Global Healthcare of Liver biopsy Market by Application
12.2.7.4 Canada Global Healthcare of Liver biopsy Market by Technology
12.2.8 Mexico
12.2.8.1 Mexico Global Healthcare of Liver biopsy Market by Procedure Type
12.2.8.2 Mexico Global Healthcare of Liver biopsy Market by End-User
12.2.8.3 Mexico Global Healthcare of Liver biopsy Market by Application
12.2.8.4 Mexico Global Healthcare of Liver biopsy Market by Technology
12.3 Europe
12.3.1 Europe Global Healthcare of Liver biopsy Market by country
1.3.3.2 Europe Global Healthcare of Liver biopsy Market by Procedure Type
12.3.3 Europe Global Healthcare of Liver biopsy Market by End-User
12.3.4 Europe Global Healthcare of Liver biopsy Market by Application
12.3.5 Europe Global Healthcare of Liver biopsy Market by Technology
12.3.6 Germany
12.3.6.1 Germany Global Healthcare of Liver biopsy Market by Procedure Type
12.3.6.2 Germany Global Healthcare of Liver biopsy Market by End-User
12.3.6.3 Germany Global Healthcare of Liver biopsy Market by Application
12.3.6.4 Germany Global Healthcare of Liver biopsy Market by Technology
12.3.7 UK
12.3.7.1 UK Global Healthcare of Liver biopsy Market by Procedure Type
12.3.7.2 UK Global Healthcare of Liver biopsy Market by End-User
12.3.7.3 UK Global Healthcare of Liver biopsy Market by Application
12.3.7.4 UK Global Healthcare of Liver biopsy Market by Technology
12.3.8 France
12.3.8.1 France Global Healthcare of Liver biopsy Market by Procedure Type
12.3.8.2 France Global Healthcare of Liver biopsy Market by End-User
12.3.8.3 France Global Healthcare of Liver biopsy Market by Application
12.3.8.4 France Global Healthcare of Liver biopsy Market by Technology
12.3.9 Italy
12.3.9.1 Italy Global Healthcare of Liver biopsy Market by Procedure Type
12.3.9.2 Italy Global Healthcare of Liver biopsy Market by End-User
12.3.9.3 Italy Global Healthcare of Liver biopsy Market by Application
12.3.9.4 Italy Global Healthcare of Liver biopsy Market by Technology
12.3.10 Spain
12.3.10.1 Spain Global Healthcare of Liver biopsy Market by Procedure Type
12.3.10.2 Spain Global Healthcare of Liver biopsy Market by End-User
12.3.10.3 Spain Global Healthcare of Liver biopsy Market by Application
12.3.10.4 Spain Global Healthcare of Liver biopsy Market by Technology
12.3.11 The Netherlands
12.3.11.1 Netherlands Global Healthcare of Liver biopsy Market by Procedure Type
12.3.11.2 Netherlands Global Healthcare of Liver biopsy Market by End-User
12.3.11.3 Netherlands Global Healthcare of Liver biopsy Market by Application
12.3.11.4 Netherlands Global Healthcare of Liver biopsy Market by Technology
12.3.12 Rest of Europe
12.3.12.1 Rest of Europe Global Healthcare of Liver biopsy Market by Procedure Type
12.3.12.2 Rest of Europe Global Healthcare of Liver biopsy Market by End-User
12.3.12.3 Rest of Europe Global Healthcare of Liver biopsy Market by Application
12.3.12.4 Rest of Europe Global Healthcare of Liver biopsy Market by Technology
12.4 Asia-Pacific
12.4.1 Asia Pacific Global Healthcare of Liver biopsy Market by country
12.4.2 Asia Pacific Global Healthcare of Liver biopsy Market by Procedure Type
12.4.3 Asia Pacific Global Healthcare of Liver biopsy Market by End-User
12.4.4 Asia Pacific Global Healthcare of Liver biopsy Market by Application
12.4.5 Asia Pacific Global Healthcare of Liver biopsy Market by Technology
12.4.6 Japan
12.4.6.1 Japan Global Healthcare of Liver biopsy Market by Procedure Type
12.4.6.2 Japan Global Healthcare of Liver biopsy Market by End-User
12.4.6.3 Japan Global Healthcare of Liver biopsy Market by Application
12.4.6.4 Japan Global Healthcare of Liver biopsy Market by Technology
12.4.7 South Korea
12.4.7.1 South Korea Global Healthcare of Liver biopsy Market by Procedure Type
12.4.7.2 South Korea Global Healthcare of Liver biopsy Market by End-User
12.4.7.3 South Korea Global Healthcare of Liver biopsy Market by Application
12.4.7.4 South Korea Global Healthcare of Liver biopsy Market by Technology
12.4.8 China
12.4.8.1 China Global Healthcare of Liver biopsy Market by Procedure Type
12.4.8.2 China Global Healthcare of Liver biopsy Market by End-User
12.4.8.3 China Global Healthcare of Liver biopsy Market by Application
12.4.8.4 China Global Healthcare of Liver biopsy Market by Technology
12.4.9 India
12.4.9.1 India Global Healthcare of Liver biopsy Market by Procedure Type
12.4.9.2 India Global Healthcare of Liver biopsy Market by End-User
12.4.9.3 India Global Healthcare of Liver biopsy Market by Application
12.4.9.4 India Global Healthcare of Liver biopsy Market by Technology
12.4.10 Australia
12.4.10.1 Australia Global Healthcare of Liver biopsy Market by Procedure Type
12.4.10.2 Australia Global Healthcare of Liver biopsy Market by End-User
12.4.10.3 Australia Global Healthcare of Liver biopsy Market by Application
12.4.10.4 Australia Global Healthcare of Liver biopsy Market by Technology
12.4.11 Rest of Asia-Pacific
12.4.11.1 APAC Global Healthcare of Liver biopsy Market by Procedure Type
12.4.11.2 APAC Global Healthcare of Liver biopsy Market by End-User
12.4.11.3 APAC Global Healthcare of Liver biopsy Market by Application
12.4.11.4 APAC Global Healthcare of Liver biopsy Market by Technology
12.5 The Middle East & Africa
12.5.1 The Middle East & Africa Global Healthcare of Liver biopsy Market by country
12.5.2 The Middle East & Africa Global Healthcare of Liver biopsy Market by Procedure Type
12.5.3 The Middle East & Africa Global Healthcare of Liver biopsy Market by End-User
12.5.4 The Middle East & Africa Global Healthcare of Liver biopsy Market by Application
12.5.5 The Middle East & Africa Global Healthcare of Liver biopsy Market by Technology
12.5.6 Israel
12.5.6.1 Israel Global Healthcare of Liver biopsy Market by Procedure Type
12.5.6.2 Israel Global Healthcare of Liver biopsy Market by End-User
12.5.6.3 Israel Global Healthcare of Liver biopsy Market by Application
12.5.6.4 Israel Global Healthcare of Liver biopsy Market by Technology
12.5.7 UAE12.5.7.1 UAE Global Healthcare of Liver biopsy Market by Procedure Type
12.5.7.2 UAE Global Healthcare of Liver biopsy Market by End-User
12.5.7.3 UAE Global Healthcare of Liver biopsy Market by Application
12.5.7.4 UAE Global Healthcare of Liver biopsy Market by Technology
12.5.8 South Africa
12.5.8.1 South Africa Global Healthcare of Liver biopsy Market by Procedure Type
12.5.8.2 South Africa Global Healthcare of Liver biopsy Market by End-User
12.5.8.3 South Africa Global Healthcare of Liver biopsy Market by Application
12.5.8.4 South Africa Global Healthcare of Liver biopsy Market by Technology
12.5.9 Rest of Middle East & Africa
12.5.9.1 Rest of Middle East & Asia Global Healthcare of Liver biopsy Market by Procedure Type
12.5.9.2 Rest of Middle East & Asia Global Healthcare of Liver biopsy Market by End-User
12.5.9.3 Rest of Middle East & Asia Global Healthcare of Liver biopsy Market Application
12.5.9.4 Rest of Middle East & Asia Global Healthcare of Liver biopsy Market by Technology
12.6 Latin America
12.6.1 Latin America Global Healthcare of Liver biopsy Market by country
12.6.2 Latin America Global Healthcare of Liver biopsy Market by Procedure Type
12.6.3 Latin America Global Healthcare of Liver biopsy Market by End-User
12.6.4 Latin America Global Healthcare of Liver biopsy Market by application
12.6.5 Latin America Global Healthcare of Liver biopsy Market by Technology
12.6.6 Brazil12.6.6.1 Brazil Global Healthcare of Liver biopsy Market by Procedure Type
12.6.6.2 Brazil Africa Global Healthcare of Liver biopsy Market by End-User
12.6.6.3 Brazil Global Healthcare of Liver biopsy Market by Application
12.6.6.4 Brazil Global Healthcare of Liver biopsy Market by Technology
12.6.7 Argentina
12.6.7.1 Argentina Global Healthcare of Liver biopsy Market by Procedure Type
12.6.7.2 Argentina Global Healthcare of Liver biopsy Market by End-User
12.6.7.3 Argentina Global Healthcare of Liver biopsy Market by Application
12.6.7.4 Argentina Global Healthcare of Liver biopsy Market by Technology
12.6.8 Rest of Latin America
12.6.8.1 Rest of Latin America Global Healthcare of Liver biopsy Market by Procedure Type
12.6.8.2 Rest of Latin America Global Healthcare of Liver biopsy Market by End-User
12.6.8.3 Rest of Latin America Global Healthcare of Liver biopsy Market by Application
12.6.8.4 Rest of Latin America Global Healthcare of Liver biopsy Market by Technology
13.Company profile
13.1 Becton, Dickinson and Company (BD)
13.1.1 Market Overview
13.1.2 Financials
13.1.3 Treatment/Services/Offerings
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Cook Medical
13.2.1 Market Overview
13.2.2 Financials
13.2.3 Treatment/Services/Offerings
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Medtronic placebos Scientific Corporation
13.3.1 Market Overview
13.3.2 Financials
13.3.3 Treatment/Services/Offerings
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Olympus Corporation
13.4.1 Market Overview
13.4.2 Financials
13.4.3 Treatment/Services/Offerings
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Veran Medical Technologies
13.5.1 Market Overview
13.5.2 Financials
13.5.3 Treatment/Services/Offerings
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Angiotech Pharmaceuticals
13.6.1 Market Overview
13.6.2 Financials
13.6.3 Treatment/Services/Offerings
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 TSK Laboratory
13.7.1 Market Overview
13.7.2 Financials
13.7.3 Treatment/Services/Offerings
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Cardinal Health
13.8.1 Market Overview
13.8.2 Financials
13.8.3 Treatment/Services/Offerings
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 SOMATEX Medical Technologies
13.9.1 Market Overview
13.9.2 Financials
13.9.3 Treatment/Services/Offerings
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Argon Medical Devices
13.10.1 Market Overview
13.10.2 Financials
13.10.3 Treatment/Services/Offerings
13.10.4 SWOT Analysis
13.10.5 The SNS View
13. Med axiom Corporation
13.10.1 Market Overview
13.10.2 Financials
13.10.3 Treatment/Services/Offerings
13.10.4 SWOT Analysis
13.10.5 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share analysis
14.3 Recent Developments
15. Use Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Bispecific Antibodies Market size was estimated USD 5.8 billion in 2022 and is expected to reach USD 106.1 billion by 2030 at a CAGR of 43.8% during the forecast period of 2023-2030.
The Cognitive Behavioral Therapy [CBT] Market size was valued at USD 159.21 billion in 2022 and is expected to reach USD 294.01 billion by 2030 and grow at a CAGR of 8.2% over the forecast period of 2023-2030.
The Dentures Market size was valued at USD 1.7 Bn in 2022 and is estimated to reach USD 3.05 Bn by 2030, with a CAGR of 7.5 % over the forecast period of 2023-2030.
The IoT Medical Devices Market Size was valued at USD 46.34 billion in 2023, and expected to reach USD 309.71 billion by 2031, and grow at a CAGR of 26.81 % over the forecast period 2024-2031.
The Healthcare Virtual Assistants Market size was valued at USD 957.61 million in 2022 and is projected to reach USD 10.44 billion with a growing CAGR of 34.8% over the forecast period 2023-2030.
The Prepacked Chromatography Columns Market Size was valued at USD 2.73 billion in 2022, and is expected to reach USD 5.49 billion by 2030 and grow at a CAGR of 9.1% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
